322 related articles for article (PubMed ID: 23988185)
21. Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer.
Warren JD; Xiong W; Bunker AM; Vaughn CP; Furtado LV; Roberts WL; Fang JC; Samowitz WS; Heichman KA
BMC Med; 2011 Dec; 9():133. PubMed ID: 22168215
[TBL] [Abstract][Full Text] [Related]
22. Performance of a second-generation methylated SEPT9 test in detecting colorectal neoplasm.
Jin P; Kang Q; Wang X; Yang L; Yu Y; Li N; He YQ; Han X; Hang J; Zhang J; Song L; Han Y; Sheng JQ
J Gastroenterol Hepatol; 2015 May; 30(5):830-3. PubMed ID: 25471329
[TBL] [Abstract][Full Text] [Related]
23.
Semaan A; van Ellen A; Meller S; Bergheim D; Branchi V; Lingohr P; Goltz D; Kalff JC; Kristiansen G; Matthaei H; Pantelis D; Dietrich D
Clin Epigenetics; 2016; 8():100. PubMed ID: 27660666
[TBL] [Abstract][Full Text] [Related]
24. Thrombospondin-4 is a putative tumour-suppressor gene in colorectal cancer that exhibits age-related methylation.
Greco SA; Chia J; Inglis KJ; Cozzi SJ; Ramsnes I; Buttenshaw RL; Spring KJ; Boyle GM; Worthley DL; Leggett BA; Whitehall VL
BMC Cancer; 2010 Sep; 10():494. PubMed ID: 20846368
[TBL] [Abstract][Full Text] [Related]
25. [Relationship of DNMT3b expression and SEPT9 methylation in theprogression of colorectal carcinogenesis].
He N; Feng G; Dou JH; Tang GB; Qian MR; Chen L; Wu KC
Zhonghua Zhong Liu Za Zhi; 2020 Nov; 42(11):925-930. PubMed ID: 33256303
[No Abstract] [Full Text] [Related]
26. Diagnostic Assessment of septin9 DNA Methylation for Colorectal Cancer Using Blood Detection: A Meta-Analysis.
Sun G; Meng J; Duan H; Zhang D; Tang Y
Pathol Oncol Res; 2019 Oct; 25(4):1525-1534. PubMed ID: 30488278
[TBL] [Abstract][Full Text] [Related]
27. SEPT9: A Specific Circulating Biomarker for Colorectal Cancer.
Song L; Li Y
Adv Clin Chem; 2015; 72():171-204. PubMed ID: 26471083
[TBL] [Abstract][Full Text] [Related]
28. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
29. Aberrant DNA methylation of ADAMTS16 in colorectal and other epithelial cancers.
Kordowski F; Kolarova J; Schafmayer C; Buch S; Goldmann T; Marwitz S; Kugler C; Scheufele S; Gassling V; Németh CG; Brosch M; Hampe J; Lucius R; Röder C; Kalthoff H; Siebert R; Ammerpohl O; Reiss K
BMC Cancer; 2018 Aug; 18(1):796. PubMed ID: 30081852
[TBL] [Abstract][Full Text] [Related]
30. Application of droplet digital polymerase chain reaction of plasma methylated septin 9 on detection and early monitoring of colorectal cancer.
Ma ZY; Chan CSY; Lau KS; Ng L; Cheng YY; Leung WK
Sci Rep; 2021 Dec; 11(1):23446. PubMed ID: 34873218
[TBL] [Abstract][Full Text] [Related]
31. A systematic review of the performance of the SEPT9 gene methylation assay in colorectal cancer screening, monitoring, diagnosis and prognosis.
Song L; Yu H; Jia J; Li Y
Cancer Biomark; 2017; 18(4):425-432. PubMed ID: 28128742
[TBL] [Abstract][Full Text] [Related]
32. Expression and DNA methylation levels of prolyl hydroxylases PHD1, PHD2, PHD3 and asparaginyl hydroxylase FIH in colorectal cancer.
Rawluszko AA; Bujnicka KE; Horbacka K; Krokowicz P; Jagodziński PP
BMC Cancer; 2013 Nov; 13():526. PubMed ID: 24195777
[TBL] [Abstract][Full Text] [Related]
33. [Hypermethylation of the CDH1, SEPT9, HLTF and ALX4 genes and their diagnostic significance in colorectal cancer].
Kostin PA; Zakharzhevskaia NB; Generozov EV; Govorun VM; Chernyshov SV; Shchelygin IuA
Vopr Onkol; 2010; 56(2):162-8. PubMed ID: 20552891
[TBL] [Abstract][Full Text] [Related]
34. Promoter hypermethylation of
Branchi V; Schaefer P; Semaan A; Kania A; Lingohr P; Kalff JC; Schäfer N; Kristiansen G; Dietrich D; Matthaei H
Clin Epigenetics; 2016; 8():133. PubMed ID: 27999621
[TBL] [Abstract][Full Text] [Related]
35. Combined SEPT9 and BMP3 methylation in plasma for colorectal cancer early detection and screening in a Brazilian population.
Lima AB; Dos Reis MB; Matsushita M; Dos Reis MT; de Oliveira MA; Reis RM; Guimarães DP
Cancer Med; 2023 Aug; 12(15):15854-15867. PubMed ID: 37338022
[TBL] [Abstract][Full Text] [Related]
36. IGFBP3 methylation is a novel diagnostic and predictive biomarker in colorectal cancer.
Perez-Carbonell L; Balaguer F; Toiyama Y; Egoavil C; Rojas E; Guarinos C; Andreu M; Llor X; Castells A; Jover R; Boland CR; Goel A
PLoS One; 2014; 9(8):e104285. PubMed ID: 25127039
[TBL] [Abstract][Full Text] [Related]
37. Application of Multiplex Bisulfite PCR-Ligase Detection Reaction-Real-Time Quantitative PCR Assay in Interrogating Bioinformatically Identified, Blood-Based Methylation Markers for Colorectal Cancer.
Bacolod MD; Mirza AH; Huang J; Giardina SF; Feinberg PB; Soper SA; Barany F
J Mol Diagn; 2020 Jul; 22(7):885-900. PubMed ID: 32407802
[TBL] [Abstract][Full Text] [Related]
38. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
[TBL] [Abstract][Full Text] [Related]
39. Methylation of the SEPT9_v2 promoter as a novel marker for the detection of circulating tumor DNA in breast cancer patients.
Matsui S; Kagara N; Mishima C; Naoi Y; Shimoda M; Shimomura A; Shimazu K; Kim SJ; Noguchi S
Oncol Rep; 2016 Oct; 36(4):2225-35. PubMed ID: 27499429
[TBL] [Abstract][Full Text] [Related]
40. Expression of BMP6 is associated with its methylation status in colorectal cancer tissue but lacks prognostic significance.
Sangplod P; Kanngurn S; Boonpipattanapong T; Ruangrat P; Sangkhathat S
Asian Pac J Cancer Prev; 2014; 15(17):7091-5. PubMed ID: 25227796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]